Trial Profile
Direct renin inhibitor (aliskiren) and carotid plaques instability markers in hypertensive patients requiring carotid endoarterectomy
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2013
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms APSHA
- 15 Sep 2012 Status changed from recruiting to suspended as reported by European Clinical Trials Database record.
- 04 Sep 2012 New trial record